NEO1 [4, 29] and NTN4 [15] are expressed in sites where NB originates, such as in the DRG of the embryonic neural crest, and we hypothesize that their functions persist throughout cancer progression, as a result of an impairment in the normal developmental signaling. This evidence concerns the gene NEO1 and cancer.